PFIZER INC Decrease in Unrecognized Tax Benefits is Reasonably Possible
PFIZER INC (PFE) had Decrease in Unrecognized Tax Benefits is Reasonably Possible of $200.00 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible · last filed 2025-02-27
- 2024-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $200.00M.
- 2023-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $100.00M.
- 2022-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $100.00M.
- 2021-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $75.00M.
| Period end | Decrease in Unrecognized Tax Benefits is Reasonably Possible |
|---|---|
| 2024-12-31 | $200.00M 10-K · filed 2025-02-27 |
| 2023-12-31 | $100.00M 10-K · filed 2024-02-22 |
| 2022-12-31 | $100.00M 10-K · filed 2023-02-23 |
| 2021-12-31 | $75.00M 10-K · filed 2022-02-24 |
| 2020-12-31 | $50.00M 10-K · filed 2021-02-25 |
| 2019-12-31 | $200.00M 10-K · filed 2020-02-27 |
| 2018-12-31 | $75.00M 10-K · filed 2019-02-28 |
| 2017-12-31 | $150.00M 10-K · filed 2018-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |